Oral treprostinil in transition or as add‐on therapy in pediatric pulmonary arterial hypertension
Abstract
Treprostinil, a prostacyclin analogue, is approved for the treatment of pulmonary arterial hypertension (PAH) in adults. Transition from parenteral to oral treprostinil has been successfully accomplished in adults with PAH but not in children. In this multicenter study, pediatric patients treated with parenteral (Cohort 1) or inhaled (Cohort 2) treprostinil were transitioned to oral treprostinil. Prostacyclin‐naïve individuals on background oral...
Paper Details
Title
Oral treprostinil in transition or as add‐on therapy in pediatric pulmonary arterial hypertension
Published Date
Jul 1, 2019
Journal
Volume
9
Issue
3
Pages
1 - 8
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History